临床试验

VIATORR Device Registry

NCT：NCT05661331 · ACTIVE_NOT_RECRUITING

NCT编号NCT05661331

状态ACTIVE_NOT_RECRUITING

开始日期2023-02-21

完成时间2028-12-31

SponsorW.L.Gore & Associates (INDUSTRY)

First posted2022-12-22

Last updated2026-10-07

简要摘要

The primary objective is to confirm the clinical performance and safety of the GORE® VIATORR® TIPS (Transjugular Intrahepatic Portosystemic Shunt) Endoprosthesis with Controlled Expansion throughout the device functional lifetime of 3 years in real world setting. The secondary objective is to collect information on quality of life after treatment with the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion. Additionally, data will be collected on the safety and performance of the GORE TIPS Set when utilized.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。